Cullinan Therapeutics (CGEM) Revenue (2021)
Cullinan Therapeutics (CGEM) posted quarterly Revenue of $18.9 million for Q1 2021.
Powered by 
Analysis
Cullinan Therapeutics (CGEM) Revenue (2021) Analysis & Trends
Cullinan Therapeutics' Revenue history runs 1 years deep, the most recent figure standing at $18.9 million for Q1 2021.
- In Q1 2021, Revenue changed N/A year-over-year to $18.9 million; the TTM figure through Dec 2021 stood at $18.9 million (changed N/A YoY), while the FY2021 annual figure was $18.9 million, changed N/A from the prior year.
- Revenue for Q1 2021 stood at $18.9 million.
- The five-year high for Revenue was $18.9 million in Q1 2021, with the low at $18.9 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Cullinan Therapeutics | 1.37 Bn | 1.37 Bn | - | - |